genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Supplement
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Coronavirus
One COVID-19 Shot, Two Approaches
Bioprocessing
Waters Opens Cambridge, MA, Collaboration Lab
Gene Therapy
Laying the Foundation for CF Therapy: An Interview with Michael Boyle
Coronavirus
Beyond the Spike: The COVAXX Approach to a COVID-19 Vaccine
Bioprocessing
Cytiva Plans $500M Expansion, 1,000 New Hires Worldwide
News
Metabolomics
Hair Loss Prevented by Modifying Stem Cell Metabolism
Cancer
Metabolic Processes in Cancer Cells Studied via Pharmaco-Metabolomics Approach
Cancer
Novel Therapeutic Target Revealed in Lung Squamous Cell Cancer
Coronavirus
Severe COVID-19 Cases Linked to Genes, Autoimmunity, and Interferon Disruption
OMICs
Regulatory RNA Control with Light
Insights
All
Trends for 2020
Bioprocessing
Observing the Performance of Planova Filters
Bioprocessing
Novel Tech Approaches for Analyzing Aggregation
Bioprocessing
Data Management in the DNA of New Gene Therapy Plant
Bioprocessing
Personalized Medicine Manufacturing Needs “Debugging Tools”
A-Lists
A-Lists
Top 50 NIH-Funded Institutions of 2020
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
June 2020 Vol. 40 No. 6
In Praise of Lesser-Sung Life Sciences Clusters
Coronavirus
Blinking Red: 25 Missed Pandemic Warning Signs
Coronavirus
Vanquishing the Virus: 160+ COVID-19 Drug and Vaccine Candidates in Development
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Metabolomics
Hair Loss Prevented by Modifying Stem Cell Metabolism
Cancer
Metabolic Processes in Cancer Cells Studied via Pharmaco-Metabolomics Approach
Bioprocessing
Observing the Performance of Planova Filters
Coronavirus
One COVID-19 Shot, Two Approaches
Magazine
All
Supplement
September 2020 Vol. 40 No. 9
Cold Cases Heat Up with New Forensic DNA Methods
September 2020 Vol. 40 No. 9
CRISPR Value Chains Support New Therapeutic Strategies
September 2020 Vol. 40 No. 9
Nonviral CRISPR Delivery Vehicles Lay the Smart Siege
Point of View
Multimodal Screening—The Future of Drug Discovery and Development
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Companies
Merck & Co
Merck & Co
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Merck & Co
Merck & Co. Commits Up to $4.2B toward Seattle Genetics Cancer Partnerships
Merck & Co
As Pressure Mounts, CEOs Commit to Science, Safety in Developing COVID-19 Vaccines
Merck & Co
COVID-19 Triple Play: Merck Acquiring Themis, Partnering with Ridgeback, IAVI
Merck & Co
Merck & Co. Partnering with ISB to Study Targets for COVID-19 Therapeutics
Merck & Co
Merck & Co. Launches Up-to-$2.5B Cancer Collaboration with Taiho, Astex
Merck & Co
Merck & Co., Sanofi Shell Out $5.2B in Deals to Strengthen...
Merck & Co
Merck Acquires TRPML1 Agonist Developer Calporta for Up to $576M
Merck & Co
Merck & Co. Eliminating 500 U.S. Sales, Commercial Jobs
Merck & Co
Merck & Co. Partners with Themis on Measles Virus Vector-Based Vaccines
Merck & Co
Merck & Co., Skyhawk Collaborate on RNA-Binding Small Molecule Therapies
Merck & Co
Merck & Co. Expands Pipeline in Cancer, Fibrosis, Autoimmune Diseases by...
Merck & Co
Merck & Co. to Acquire Peloton for Up to $2.2B, Adding...
Merck & Co
Citing “Strong Sales,” Pension Manager Buys Partial Keytruda Rights for $1.3B
Merck & Co
Merck & Co. Plans Jobs Cuts, Shutdowns in Up-to-$1.2B Manufacturing Restructuring
Merck & Co
Merck, King’s Launch $344M+ Chronic Pain Drug Collaboration
Load more
Scroll Up
Please share your location to continue
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
